A standardization study of the Czech version of the Mississippi Aphasia Screening Test (MASTcz) in stroke patients and control subjects
Autor: | Eva Bártková, Ladislav Dušek, Kateřina Šajgalíková, Josef Bednařík, Milena Košťálová, Alice Dolenská |
---|---|
Rok vydání: | 2008 |
Předmět: |
Adult
Male Czech Pediatrics medicine.medical_specialty Time Factors Stroke patient Neuroscience (miscellaneous) Speech Therapy Sensitivity and Specificity Severity of Illness Index Young Adult 03 medical and health sciences 0302 clinical medicine Aphasia Developmental and Educational Psychology Humans Medicine Prospective Studies 030212 general & internal medicine Western Aphasia Battery Stroke Aged Aged 80 and over Observer Variation Aphasia screening test Language Tests business.industry Stroke Rehabilitation Construct validity Recovery of Function Middle Aged Control subjects medicine.disease language.human_language 3. Good health ROC Curve Case-Control Studies Physical therapy language Female Neurology (clinical) medicine.symptom business 030217 neurology & neurosurgery |
Zdroj: | Brain Injury. 22:793-801 |
ISSN: | 1362-301X 0269-9052 |
DOI: | 10.1080/02699050802372190 |
Popis: | To assess the criterion and construct validity and inter-rater reliability of the Czech version of the Mississippi Aphasia Screening Test (MASTcz).Prospective evaluation of consecutive inpatients admitted to the stroke unit of a university hospital within 60 days of onset of a unilateral left hemispheric ischaemic or haemorrhagic stroke with documented aphasia (LHA + ; n = 149). As control groups, unilateral right hemisphere stroke patients without aphasia (RHA-; n = 45) and healthy volunteers recruited from the community to comprise a non-patient control group (CG; n = 243) were examined.Data collection included administration of MASTcz (in 52 LHA + patients, repeated by two blinded observers within 24 hours), Edinburgh inventory, Minimental State Examination score and chart review. The presence of aphasia was documented with a standard clinical logopaedic examination and also with the Western Aphasia Battery (WAB) in 45 LHA+ patients.MASTcz displayed high criterion validity (with sensitivity and specificity above 90%) in discrimination between stroke aphasia patients and both control subjects and RHA- stroke patients, high construct validity (close correlation with WAB score; r = 0.933), and acceptable interrater reliability.Analyses suggest the usefulness of MASTcz as a reliable and valid screening tool for the detection of aphasia and tracking of its progress. |
Databáze: | OpenAIRE |
Externí odkaz: |